Moleculin Biotech, Inc. (MBRX): Price and Financial Metrics
MBRX Price/Volume Stats
| Current price | $2.73 | 52-week high | $15.75 |
| Prev. close | $2.83 | 52-week low | $2.12 |
| Day low | $2.70 | Volume | 31,100 |
| Day high | $2.93 | Avg. volume | 33,328 |
| 50-day MA | $2.54 | Dividend yield | N/A |
| 200-day MA | $4.23 | Market Cap | 8.20M |
MBRX Stock Price Chart Interactive Chart >
Moleculin Biotech, Inc. (MBRX) Company Bio
Moleculin Biotech, Inc., a preclinical and clinical-stage pharmaceutical company, focuses on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia. The company was founded in 2015 and is based in Houston, Texas.
MBRX Price Returns
| 1-mo | 7.48% |
| 3-mo | 14.23% |
| 6-mo | N/A |
| 1-year | -67.56% |
| 3-year | -91.73% |
| 5-year | -97.08% |
| YTD | -78.80% |
| 2023 | -19.02% |
| 2022 | -43.01% |
| 2021 | -61.11% |
| 2020 | -12.89% |
| 2019 | -12.01% |
Loading social stream, please wait...